Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07073807 · ClinicalTrials.gov registry record · NA
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
A NA study of Cancer and Neoplasms, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 5
- Study locations
NCT07073807: Recruiting NA study of Cancer and Neoplasms, sponsored by University of California, Irvine.
NCT07073807 is a NA study of Cancer and Neoplasms that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 35 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07073807, a NA study of Cancer and Neoplasms, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 5
- Study locations
Study Summary
New oral anticancer treatments have improved survival across cancer types but introduced challenges in medication adherence and symptom management. The SMART pilot trial will test a new mobile health intervention that facilitates remote adherence and symptom monitoring, patient-provider communication outside of clinic visits regarding the use of oral anticancer treatments, and support for financial and social needs, as well as health literacy support, for 30 English- and Spanish-speaking patients. This study will increase understanding of barriers and facilitators to the use of the proposed mHealth intervention.
Primary Outcome
Feasibility will be assessed by the proportion of participants using TAPPT® adherence monitoring for the duration of therapy and the proportion completing all available biweekly surveys.
Interventions
- BEHAVIORAL SMART Intervention using TAPPT® for Adherence, Symptom, Financial, and Social Needs Monitoring
Study Locations (5)
California
- Chao Family Comprehensive Cancer Center and Ambulatory Care building - Irvine
- UCI Health Cancer Center - Newport - Newport Beach
- UCI Health Pacific Breast Care Center - Newport Beach
- UCI Health Chao Family Comprehensive Cancer Center - Orange
- UCI Health - Yorba Linda - Yorba Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-08-26 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT07073807 shows while recruiting
NCT07073807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which SMART Intervention using TAPPT® for Adherence, Symptom, Financial, and Social Needs Monitoring is the first listed.
NCT07073807 lists 5 locations in 1 state (California).
Frequently Asked Questions
What is clinical trial NCT07073807 about?
NCT07073807 is a clinical study titled "Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy". New oral anticancer treatments have improved survival across cancer types but introduced challenges in medication adherence and symptom management. The SMART pilot trial will test a new mobile health intervention that facilitates remote adherence and symptom monitoring, patient-provider communicatio...
What is the current status of trial NCT07073807?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-08-26. Estimated completion is 2026-10.
What conditions does trial NCT07073807 study?
This clinical trial studies the following conditions: Cancer, Neoplasms.
What interventions are being tested in trial NCT07073807?
The interventions under investigation include: SMART Intervention using TAPPT® for Adherence, Symptom, Financial, and Social Needs Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT07073807?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07073807 being conducted?
This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07073807's enrollment target sits among peer trials
35 488th of 615 higher than 124 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI